课题基金 / 基金详情

Reducing the signs and symptoms of Huntingtons disease by manipulating endocannabinoid tone.

Reducing the signs and symptoms of Huntingtons disease by manipulating endocannabinoid tone.
通过控制内源性大麻素音调来减少亨廷顿病的体征和症状。
批准号:
272476
负责人:
Laprairie Robert B
金额:
$0.0万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-10-01 至 2015-10-01

项目摘要

项目成果

Laprairie Robert B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The endocannabinoid system is a system of receptors and enzymes that interact with cannabinoids, molecules that are naturally produced by the body and related to the active ingredient in marijuana, THC, to cause context-specific effects. In the brain, the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Novel Type 1 Cannabinoid Receptor Positive Allosteric Modulators for Infantile Spasms
  • 批准号:
    410481
  • 项目类别:
    Operating Grants
  • 资助金额:
    $50.44万
  • 财政年份:
    2019
  • 负责人:
    Laprairie Robert B
  • 依托单位:
Novel Type 1 Cannabinoid Receptor Allosteric Modulators
  • 批准号:
    367883
  • 项目类别:
    Operating Grants
  • 资助金额:
    $13.66万
  • 财政年份:
    2017
  • 负责人:
    Laprairie Robert B
  • 依托单位:
Characterization of ligand bias at the type 1 cannabinoid receptor
Regulation of type 1 cannabinoid receptor expression in Huntington's disease.
  • 批准号:
    224312
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $1.27万
  • 财政年份:
    2011
  • 负责人:
    Laprairie Robert B
  • 依托单位:
海外基金